like Plaintiff, have suffered serious autoimmune defects; Vision loss; Suffered sporadic hearing loss; significant inflammation in his body; cerebrospinal fluid pressure; aggressive; exhibit dangerous behavior; nerve pain; fibromyalgia; 09-NOV-2018 fisrt dose, 17-DEC-2019 second dose; Depression; Dysautonomia/ unable to stand; Postural Orthostatic Tachycardia Syndrome (POTS); seizures; This initial spontaneous report has been received from a lawyer regarding a case in litigation, concerning a 11-year-old male patient (pt). The pt's pertinent medical history, concurrent conditions, concomitant medications and previous drug reactions, or allergies were not reported. On 09-NOV-2018, the pt was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (dose, strength, vaccination scheme, route of administration, anatomical location lot number and expiration date were not provided), administered for preventing cancer. It has been reported that the pt sustained serious autoimmune, autonomic, and neurological Injuries as a result. It was reported that on an unknown date in 2018, (reported as almost immediately after receiving that vaccination), the pt began to experience fatigue and anxiety, as well as mood swings, trouble sleeping, light-headedness and confusion. On an unknown day in January 2019, the pt began to have more severe anxiety and depression; and on 11-MAR-2019, the pt's family sought help with a counselor and, later that month, a psychiatrist. Along with this he continued to experience stomach pains and light-headedness. On unspecified day in April 2019, he began vomiting daily and had diarrhea. On an unreported day in May 2019, the pt was diagnosed with gastroparesis. Over the summer, the vomiting stopped, the pt continued to have anxiety, depression and trouble sleeping. On 08-SEP-2019, he began vomiting again, which continued for weeks. On an unknown day in September 2019, the pt began fainting, sometimes remaining unconscious for as long as 30 minutes at a time. On 01-OCT-2019, the pt fainted on his front lawn while waiting for the school bus. In October 2019, the pt was seen at the clinic, where he was diagnosed with dysautonomia and postural orthostatic tachycardia syndrome (POTS) after a tilt table test, and was prescribed new medication, but he continued to have fainting spells. Soon thereafter, he began staggering when he walked and, eventually, was unable to stand. On 17-DEC-2019, the pt was vaccinated with the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (dose, strength, vaccination scheme, route of administration, anatomical location lot number and expiration date were not provided) (inappropriate schedule of product administration). Thereafter, he suffered sporadic hearing and vision loss, and continued to lose consciousness daily. The family sought additional treatment of the pt's condition and met with a doctor, on an unspecified day in February 2020, who adjusted some of the medications and ordered intravenous (IV) fluid therapy. In the following months, he experienced numerous instances where would faint and, upon walking, would be aggressive or exhibit dangerous behavior, but once he recovered, he would not remember these episodes. As the months progressed, so did the symptoms; he was seen by physicians and specialists for his complaints which now included: fatigue, severe anxiety and depression, mood swings, angry outbursts, aggression, joint and muscle pain, nerve pain, inability to walk, syncope, seizures, heart palpitations, trouble sleeping, light-headedness, confusion, stomach pains, vomiting and diarrhea and was confined to a wheelchair for a year and half. On 16-NOV-2020, the pt was unresponsive after having another syncope episode and was taken to the ER. On 11-DEC-2020, he had a lumbar puncture, which showed a high cerebrospinal fluid pressure, and had to return to the hospital a few times over the next three months to address and treat the elevated pressure. On an unknown date in April 2021, he began sessions with a therapist using low energy neurofeedback system (LENS) neurofeedback; and, , on an unspecified date, he underwent extensive physical therapy to regain his ability to walk and run. As a result of his post- quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, he has been unable to engage in activities that a young person would normally enjoy. He could no longer be physically active or participate in activities he previously was able to do. The pt has struggled to keep up with his studies and has been receiving homebound education services for at least three years. His latest labs showed significant inflammation in his body. Based upon his chronic and severe symptoms, the pt has been diagnosed with various medical conditions, including but not limited to, those previously reported and fibromyalgia. As a proximate result of the company's alleged wrongful acts and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) manufacturing defects, pt suffered and continued to suffer severe and permanent physical injuries and associated symptomology and suffered severe and permanent emotional injuries, including pain and suffering. Also, he had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with his autoimmune disease and other injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of his Gardasil-induced injuries, he suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and he would continue to incur those losses and expenses in the future. At the time of reporting, the pt had not recovered from the events. The reporter considered all the aforementioned events to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL).   All the events were considered as disabling by reporter.  Upon internal review, the events of  blindness, deafness, seizure, CSF pressure increased, autoimmune disorder were determined to be medically significant.